Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Well then release the results before the call........odd. But everything nadar does is odd.
Conference call on unblinded data that hasnt been unblinded yet? How does that make sense??? Maybe monday am??
If you can ignore the noise. Long hauler data release i hope is released in July.....
I can already see FDA removing woodcock on recent fiasco hitting the wires.
Then long hauler data comes out....fda: oh shit...drug works.
We made a mistake in our previous assessment of leronlimab under the wrong leadership. We now know the more recent data shows clinical efficacy for treatment of critically ill and long haulers....
I can already see this playing out. Ignore the noise. You csnt deny science...especially as the general public starts to see what works.
Some are working pretty hard to get nadar out. Im on the fence but i defn think he is a prick.....he cant even keep his stock above $2 yet makes 3 digit claims. Stock price is getting beat up. Confidence is gone. Distractions of lawsuits, etc are keeping focus away from sone very game changing catalysts. But for now the market doesnt care. Poor performance. No real view on HIV progress. No one believes them anyways, long hauler data hooefully we see in july. Doubtful.
Seen this so many times and its just a distraction. They wont drive positive change. They need to pull their head out if their a$$. They are basically retail holders (and there is always a group) that think they can do better. But they are disconnected from reality and generally dont add value AT ALL. Stick with the real estate and pepperoni pizza recipes. This is a small distraction and shorts will jump all over it.
These f$$king clowns! Go back to running your realestate businesses and pizza stores. This is embarrassing. And i have enough shares to make the list and not at the very bottom. These clowns will add zero. Let the company execute on its strategy. Most are in the money anyways. Long hauler data around the corner. 35M shares of bag holders...a couple who just trade in and out. Get the f out of here. Thanks for embarrassing the company. Probably barely know what a CCR5 receptor is. Its not like the pepperoni on the pizza.
Do we know if the FDA accepted the new protocol for additional 140 patients that was filed?
I loaded up here at $2.20....was going to wait til $2 but whatever.,...went from 40K shares to 100K shares.
Per the 8k the avg age between the two groups was almost the same....58 vs 59.
Thank you. And the FDA will approve this as a primary endpoint?
Why did the primary endpoint for the 140 patients change in the new protocol for critically ill???? They already achieved 6 days with statistical power.
2. Shortened time to recovery: The average length of hospital stay was reduced by 6 days for patients who received leronlimab with "commonly used COVID-19 treatments," also referred to as "Standard of Care" or "SoC, " compared to placebo patients who received SoC only, with a statistically significant p-value of 0.005.
Predictions of PPS tomorrow?
Nadar emailed you that there would be a press release tonight or tomorrow am.....come one?? Seriously....??
Do you have a link.
CTmedic....correct me if i am wrong but they didnt report on all criticslly ill patients. They reported on a subgroup of critically ill...... “mechanically ventilated critically ill patients”
Well no surprise we did not meet primary endpoint of the trial. Had they hit it they would have PR’d right away. But was still really hopeful. I think the focus is obviously critically ill because we missed all endpoints for severe. It’s obvious based on delays they needed to mine the data to determine of a subset benefited from the drug. I dont know if 24% is even significant when you are talking 62 patients and 17 vs 13 died. Is that significant. Prob not significant enough. I think we’ll be months away from knowing until they complete critically ill number of patients required to evaluate.......
I feel like a dope for not selling at $7. I hope we can hold the current valuation but i think we get hammered.
This is exactly the sloppiness of this company. Needs to new mgmt .... period.
The company owns the data.....the FDA historically NEVER NEVER tells a company not to do a press release.....they dont give a shit about investors and PRs. They follow a strict process for bringing drugs to market. Did tbey tell any of the vaccine companies to not release their topline results before EUA....hell no.
I also think in nadar’s clock 2-3 weeks is months away....dont think we see resolution in 2-3 weeks.
CT Medic....point taken. 2-3 weeks will be great to see results. Had nadar not said we will release data hipefully next week i’s be more optimistic. I still think they missed primary endooint and he said screw PRing lets just move forward with supplyimg data to fda and hope its good enough for approval......
Put yourself in companies shoes. If you hit your primary endpoint you PR the news to the world. This also puts additional pressure on the FDA. If you miss it but there are pockets of data that possibly support EUA....You send the unblinded data and hope the agencies clear a path to market for you. Like i said. Im pretty pessimistic at this point and hoping im wrong. If it smells like a duck, quacks like a duck, its probably a duck. Holding on to my shares as the CD10 data was good IMO and i like their prospects with HIV, cancer.....but im concerned. I think tbey should have stuck with the DSMC recommendation to evaluate at day 42. Im hopeful they have the data for both placebo and the leronlimab arm at day 42.....so even if they missed at day 28 hopefully there is statistical significance at day 42
Charm...thx for reply.....but seriosuly.....they dilute the crap out of PRs.
But reporting trial results is a bigger reason to have a PR than any other. If they hit their primary endpoint they would prob PR it every day for a week given their number of PRs that are worthless. The question is to me, if if they have enough in the data to justify a EUA . Maybe for just a subgroup that clearly had positive outcomes. At this point i am hopeful the company has enough to get an EUA or.....possibly might be guided to another trial. I dont know but im not optimistic at this point. And i truly hope i am wrong.
No way dieselpro. Im
Long here but perhaps the only long not surprised to see a beating on that press release. I think they missed their primary endpoint. The CEO would blast out a press release if they hit their primary endpoint. Period.
If they hit their primary end point and met statistical significance is there any possible way they would not press release that??? Give me an example of a company waiting for discussions with fda that only released results after it received path forward from fda after hitting primary endpoint. Im long but im not thrilled. No way they wouldnt release the data if they hit the primary endpoint. My guess is data is good for a sub group of the population and are hoping to get EUA for that subgroup. It just doesnt make sense not to release the results of whether it met primary or secondary endpoints.
Please convince me i am wrong would love to be wrong and hope I am. But i dont think so. Not adding up. Period.
misiu.....are you not concerned with the amount of time it is taking the company to report top line results.....i cant imagine why it would take so long to report mortality (its a 293 patient trial!!!).....I hope im wrong but i see red flags starting to raise.
My guess with these baffoons you might never see the data.
Someone please defend NP.... “ we hope to release data next week”..... “we expect to unblind data mid January”.........etc etc.
Liar or incompetent? Since the first time i heard this guy on an investor call it was clear he is full of shit. If he isnt gone within a 6 mo after data release....IF we even get data......my take is top line results are more than complete. They are either sitting on endpoints not met.....or they sent the unblinded data to the fda to see if they can get an EUA before shading data with investor.
Either way, something smells a little fishy with the delay here in releasing top line results. The market is starting to question a little more hence the sell off today. Im long but feel like a sucker.......this has red flags written all over it and there is no question the CEO is full of shit.
The company cant even release the data based on when they said they will. But its the FDAs fault that they dont have the data yet?
What nader mesnt to say was not “we hope to release the data next week” to “we hope to never release the data.” This MF is a LIARRRRR.....
Where are the topline results
Why does NP mislead his investors. He said the week before last he hopes for a data release next week. Well next week came and went. Surely he knew data wasnt going to be released last week. No other way to describe him other then a fxxking liar. All will be forgiven if they release data this week. Seems unlikely.
Closing green today.
Its amazing to me both longs and shorts hear what they want to hear. Sometimes guilty here.......but i dont believe he would say they are excited to rekease CD12 if it was bad....nor do I think would he be playing the i told you so card in advance if it was bad. (At 30 cents he saud double digits and it hit $10).....and now he saying forget double digits we are going to tripple digits. He just told you the data is good. Maybe im wrong. But i think he knows what he is sitting on.
“....We are going to 3 digits...” no way he would say that if the data was bad....no way.
Surprised they have not reported top line data. How many deaths should be pretty easy to count in each arm.
Traders love volatility. Uncertainty is the key ingredient that allows for good trading.....if you want the least amount of traders that further impact volatility......then you invest in stocks like proctor and gamble....the reason day traders are overwhelmingly in mostly speculative companies and “news” plays is because binary events drive huge moves. Speculation allows for good long and short opportunities. CYDY is still very speculative. Im long here but still cautiously optimistic. I do think the PR yesterday might take us back to $7+ next week
Only company fundamentals and minimized uncertainty alliws for the equity to not be volatile....until then...buckle up.....we will be on a ride until FDA approves the drug for EUA for covid or until we receive approval for another indication. Good data release mid jan will send this to 15+ tho.
CYDY and HGEN typically trade together as front runners for critically ill. HGEN up today. CYDY down. Doesnt mean anythung.....just a data point. Both have been rallying. Both have data indicating Very promising drugs for multiple indications. The difference today appears to be CYDY has the bears raiding in. They cherry Picked the right day to do it. CFO selling shares and pretty big wall at $7.......Be interesting to see last hour of trading. I expect it to trade up from here.....i i think it closes around $6.25.......just a guess.
That was picture perfect bear raid. The resistance was very evident at $7.....was perfect opportunity to take it down....only took ~2M shares total trades from $7 down to $5......took out stop losses on the way down....on the bright side they couldnt get it under $5......defn a bear raid....look forward to the longs ripping their axx cheecks back to $10
No. 42 days was for DSMC.
Nadar said on last call because enrollment so close to finishing they are just going to go with FDA protocol....trial (full entrollment + 28 days).
So data readout by mid January IMO.